81
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Effects of the Novel Coronavirus Pandemic on the Identification and Care of Critically Ill Emergency Patients Not Infected with COVID-19

, , , , &
Pages 2661-2672 | Received 29 Aug 2023, Accepted 10 Nov 2023, Published online: 04 Dec 2023

References

  • Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395(10223):470–473. PMID: 31986257; PMCID: PMC7135038. doi:10.1016/S0140-6736(20)30185-9
  • Feng ZH, Cheng YR, Chen J, Ye L, Zhou MY, Wang MW. Chinese medical personnel against the 2019-nCoV. J Infect. 2020;80(5):578–606. PMCID: PMC7126162. doi:10.1016/j.jinf.2020.02.011
  • Desai R, Singh S, Parekh T, et al. COVID-19 and shock: a cautionary tale for elderly patients from a pooled analysis. Ann Emerg Med. 2020;75(6):789–791. PMCID: PMC7151519. doi:10.1016/j.annemergmed.2020.04.014
  • Sima YJ. White paper on China’s Actions to combat COVID-19 [EB/ OL]. Beijing: Website of The State Council Information Office of the People’s Republic of China; 2020. Available from: http://www.scio.gov.cn/zfbps/32832/Document/. Accessed November 22, 2023.
  • Expert Consensus group on emergency pre-screening triage. Expert consensus on emergency predetection and triage. Chinese Journal of Emergency Medicine. 2018;27(6):599–604. 10.3760/cma.j.issn.1671-0282.2018.06.006
  • Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265–269. PMID: 32015508; PMCID: PMC7094943. doi:10.1038/s41586-020-2008-3
  • The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) - China, 2020. China CDC Wkly. 2020;2(8):113–122. PMID: 34594836; PMCID: PMC8392929. doi:10.46234/ccdcw2020.032
  • Steffens I. A hundred days into the coronavirus disease (COVID-19) pandemic. Euro Surveill. 2020;25(14):2000550. PMID: 32290905; PMCID: PMC7160442. doi:10.2807/1560-7917.ES.2020.25.14.2000550
  • Henry BM, Lippi G. Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): pooled analysis of early reports. J Crit Care. 2020;58:27–28. PMID: 32279018; PMCID: PMC7118619. doi:10.1016/j.jcrc.2020.03.011
  • Sohrabi C, Alsafi Z, O’Neill N, et al. World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020;76:71–76. PMID: 32112977; PMCID: PMC7105032. doi:10.1016/j.ijsu.2020.02.034
  • World Health Organization. WHO director-general’s opening remarks at the media briefing on COVID-19 - 5 February 2020. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-The-media-briefing-on-covid-19---5-february-2020. Accessed November 22, 2023.
  • Hermans C, Weill A, Pierce GF. The COVID-19 pandemic: new global challenges for the haemophilia community. Haemophilia. 2020;26(3):371–372. PMID: 32246879. doi:10.1111/hae.14001
  • Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020;395(10223):473–475. PMID: 32043983; PMCID: PMC7134694. doi:10.1016/S0140-6736(20)30317-2
  • Sarkar S, Karmakar S, Basu M, Ghosh P, Ghosh MK. Neurological damages in COVID-19 patients: mechanisms and preventive interventions. MedComm. 2023;4(2):e247. PMID: 37035134; PMCID: PMC10080216. doi:10.1002/mco2.247
  • Ferrando C, Mellado-Artigas R, Gea A, et al.; de la Red de UCI Española para COVID-19. Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-Cov-2 in Spain: a prospective, cohort, multicentre study. Rev Esp Anestesiol Reanim. 2020; 67(8):425–437. English, Spanish. PMID: 32800622; PMCID: PMC7357496. doi:10.1016/j.redar.2020.07.003
  • Xu J, Yang X, Yang L, et al. Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China. Crit Care. 2020;24(1):394. PMID: 32631393; PMCID: PMC7336107. doi:10.1186/s13054-020-03098-9
  • Arentz M, Yim E, Klaff L, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state. JAMA. 2020;323(16):1612–1614. PMID: 32191259; PMCID: PMC7082763. doi:10.1001/jama.2020.4326
  • Calver JF, Fabbri L, May J, Jenkins RG. COVID-19 in patients with chronic lung disease. Clin Chest Med. 2023;44(2):385–393. PMID: 37085227; PMCID: PMC9678841. doi:10.1016/j.ccm.2022.11.013
  • Kole C, Stefanou Ε, Karvelas N, Schizas D, Toutouzas KP. Acute and post-acute covid-19 cardiovascular complications: a comprehensive review. Cardiovasc Drugs Ther. 2023;20:1–16. PMID: 37209261; PMCID: PMC10199303. doi:10.1007/s10557-023-07465-w
  • AlQadheeb N, AlMubayedh H, AlBadrani S, et al. Impact of common comorbidities on antimicrobial consumption and mortality amongst critically ill COVID-19 patients: a retrospective two center study in Saudi Arabia. Clin Infect Pract. 2023;19:100229. PMID: 37168925; PMCID: PMC10156636. doi:10.1016/j.clinpr.2023.100229
  • Halpin DMG, Faner R, Sibila O, Badia JR, Agusti A. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? Lancet Respir Med. 2020;8(5):436–438. PMID: 32251625; PMCID: PMC7270536. doi:10.1016/S2213-2600(20)30167-3
  • Liu NN, Tan JC, Li J, Li S, Cai Y, Wang H. COVID-19 pandemic: experiences in china and implications for its prevention and treatment worldwide. Curr Cancer Drug Targets. 2020;20(6):410–416. PMID: 32286947. doi:10.2174/1568009620666200414151419
  • The Comprehensive Group of the Joint Prevention and Control Mechanism of The State Council in response to the Novel Coronavirus Infection. Notice on issuing the overall plan of implementing the “class b and b management” for the novel coronavirus infection. National Health Commission of the People’s Republic of China[EB/ OL]; 2022. Available from: http://www.nhc.gov.cn/xcs/zhengcwj/202212/e97e4c449d7a475794624b8ea12123c6.shtml. Accessed November 22, 2023.
  • Chinese Thoracic Society; Chinese Association of Chest Physicians. 新型冠状病毒肺炎防治专家意见 [Guide for the prevention and treatment of coronavirus disease 2019]. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43(6):473–489. Chinese. Chinese. doi:10.3760/cma.j.cn112147-112147-20200321-00392
  • Balakrishnan A, Jacob MM, Senthil Kumar P, et al. Strategies for safe management of hospital wastewater during the COVID-19 pandemic. Int J Environ Sci Technol. 2023;13:1–16. PMID: 36817164; PMCID: PMC9925218. doi:10.1007/s13762-023-04803-1
  • Jiang JM, Feng QM, Fu YM, et al. Wu W. Changes of disease spectrum in emergency critical patients during the epidemic period of novel coronavirus Omicron variant.Chinese. J Critical Care Med. 2022;42(7):596–599. doi:10.3969/j.issn.1002-1949.2022.07.009
  • Romano A, Sotis C, Dominioni G, Guidi S. The scale of COVID-19 graphs affects understanding, attitudes, and policy preferences. Health Econ. 2020;29(11):1482–1494. PMID: 32844495; PMCID: PMC7461444. doi:10.1002/hec.4143
  • George PM, Wells AU, Jenkins RG. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Respir Med. 2020;8(8):807–815. PMID: 32422178; PMCID: PMC7228727. doi:10.1016/S2213-2600(20)30225-3
  • Alali AS, Alshehri AO, Assiri A, et al. Demographics, comorbidities, and outcomes among young and middle-aged COVID-19 patients in Saudi Arabia. Saudi Pharm J. 2021;29(8):833–842. PMID: 34177315; PMCID: PMC8213516. doi:10.1016/j.jsps.2021.06.005
  • Al-Otaiby M, Almutairi KM, Vinluan JM, et al. Demographic characteristics, comorbidities, and length of stay of covid-19 patients admitted into intensive care units in Saudi Arabia: a nationwide retrospective study. Front Med Lausanne. 2022;9:893954. PMID: 35911421; PMCID: PMC9325959. doi:10.3389/fmed.2022.893954
  • Barkhordarian M, Behbood A, Ranjbar M, Rahimian Z, Prasad A. Overview of the cardio-metabolic impact of the COVID-19 pandemic. Endocrine. 2023;80(3):477–490. PMID: 37103684; PMCID: PMC10133915. doi:10.1007/s12020-023-03337-3
  • Schlesinger S, Lang A, Christodoulou N, et al. Risk phenotypes of diabetes and association with COVID-19 severity and death: an update of a living systematic review and meta-analysis. Diabetologia. 2023;19:1–18. PMID: 37204441; PMCID: PMC10198038. doi:10.1007/s00125-023-05928-1
  • SeyedAlinaghi S, Karimi A, Afsahi AM, et al. The effectiveness of face masks in preventing covid-19 transmission: a systematic review. Infect Disord Drug Targets. 2023;23(8). PMID: 37259934. doi:10.2174/1871526523666230601090905
  • Naorungroj T, Viarasilpa T, Tongyoo S, et al. Characteristics, outcomes, and risk factors for in-hospital mortality of COVID-19 patients: a retrospective study in Thailand. Front Med Lausanne. 2023;9:1061955. PMID: 36687414; PMCID: PMC9846200. doi:10.3389/fmed.2022.1061955
  • Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D. COVID-19 does not lead to a “typical” acute respiratory distress syndrome. Am J Respir Crit Care Med. 2020;201(10):1299–1300. PMID: 32228035; PMCID: PMC7233352. doi:10.1164/rccm.202003-0817LE
  • The Comprehensive Team of the Joint Prevention and Control Mechanism of The State Council for the Novel Coronavirus Infection. Notice on issuing four documents including the implementation measures for nucleic acid testing for the prevention and control of the novel coronavirus pneumonia epidemic. Website of National Health Commission of the People’s Republic of China[EB/ OL]; 2022. Available from: https://www.gov.cn/xinwen/2022-11/21/content_5728107.htm. Accessed November 22, 2023.
  • Khan S, Hasan SS, Bond SE, Conway BR, Aldeyab MA. Antimicrobial consumption in patients with COVID-19: a systematic review and meta-analysis. Expert Rev Anti Infect Ther. 2022;20(5):749–772. PMID: 34895002. doi:10.1080/14787210.2022.2011719
  • Saha A, Ahsan MM, Quader T-U, et al. Characteristics, management and outcomes of critically ill COVID-19 patients admitted to ICU in hospitals in Bangladesh: a retrospective study. J Prev Med Hyg. 2021;62(1):E33–E45. PMID: 34322614; PMCID: PMC8283638. doi:10.15167/2421-4248/jpmh2021.62.1.1838